+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Global Cell Therapy Technologies Market by Therapy Type, Therapeutic Area, Region - Forecast up to 2030- Product Image
Global Cell Therapy Technologies Market by Therapy Type, Therapeutic Area, Region - Forecast up to 2030- Product Image
Sale

Global Cell Therapy Technologies Market by Therapy Type, Therapeutic Area, Region - Forecast up to 2030

  • PDF Icon

    Report

  • 201 Pages
  • January 2024
  • Region: Global
  • IHR Insights
  • ID: 5920689
UP TO OFF until Dec 31st 2024
10% Free customization
Description Jump to:
10% Free customization

This report comes with 10% free customization, enabling you to add data that meets your specific business needs.
Cell therapy is important in giving diagnostic and prognostic information for a variety of disorders, including HIV/AIDS, cancer, and infectious diseases. It helps academics and healthcare practitioners to acquire insights into disease causes, illness development, and therapy responses using novel cellular-based techniques. Global population expansion, climate change, and greater human-animal interaction have produced an environment conducive to the genesis of novel viral epidemics. Cell therapy research and applications are critical in tackling these issues because they provide enhanced diagnostic tools, therapeutic approaches, and a better knowledge of disease causes.

Cell biology research is primarily concerned with the development of novel medicines such as stem cell and gene therapies. High-quality tools, reagents, and associated goods are required for reliable findings. Meeting regulatory rules and maintaining demanding quality standards in cell biology research, on the other hand, comes at a considerable expense. This is a problem for institutes and small businesses with limited funds, as they may be unable to acquire pricey research products.

Precision medicine is a developing approach to illness treatment and prevention that takes into account genetic, environmental, and lifestyle factors. It entails selecting drugs for each patient depending on their individual condition and medical history. Oncology has made significant advances in precision medicine, even as its use expands to diverse disorders. This personalised approach to diagnosis, treatment, and prevention makes better judgements by utilising full patient information such as genetics, environment, and lifestyle.

The segmentation coverage of the study is provided below:

Cell Therapy Technologies Market based on Therapy Type

  • Allogeneic Therapies
  • Stem Cell Therapies
  • Hematopoietic Stem Cell Therapies
  • Mesenchymal Stem Cell Therapies
  • Non-Stem Cell Therapies
  • Keratinocytes & Fibroblast-based Therapies
  • Others
  • Autologous Therapies
  • Stem Cell Therapies
  • BM, Blood, & Umbilical Cord-derived Stem Cells
  • Adipose derived cells
  • Others
  • Non-Stem Cell Therapies
  • T-Cell Therapies
  • CAR T Cell Therapy
  • T Cell Receptor (TCR)-based

Cell Therapy Technologies Market based on Therapeutic Area

  • Oncology
  • Cardiovascular Disease (CVD)
  • Musculoskeletal Disorders
  • Dermatology
  • Others

Cell Therapy Technologies Market based on Geography

North America
  • US
  • Canada
Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Rest of Europe (RoE)
Asia Pacific (APAC)
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific (RoAPAC)
Latin America (LATAM)
  • Brazil
  • Argentina
  • Rest of South America
Middle East and Africa (MEA)
  • UAE
  • Turkey
  • Saudi Arabia
  • South Africa
  • Rest of Middle East & Africa
On the basis of cell type, the stem cell segment led the worldwide cell therapy market in 2019, and this trend is expected to continue during the forecast period, as they are gaining popularity as a result of different government initiatives. The number of stem cell banks is increasing in developing countries, which is fueling the expansion of the cell treatment industry. Furthermore, increased understanding of stem cell preservation has a beneficial impact on the cell treatment market growth. Furthermore, the allogenic treatment segment dominated the market in 2019. This therapy is favourable because it includes the generation of one's own immune stem cells, which can destroy cancer cells that survive treatment with high-dose cytotoxic medicines.

It is divided into two types of therapies: autologous and allogenic. The market is divided by therapeutic areas such as malignancies, musculoskeletal diseases, autoimmune disorders, dermatology, and others. It is divided into two types of end-users: hospitals and clinics and academic and research institutes. The market is divided into four regions: North America (the United States, Canada, and Mexico), Europe (Germany, the United Kingdom, France, Spain, Italy, and the rest of Europe), Asia-Pacific (Japan, China, India, Australia, and the rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and the rest of LAMEA).

The hospitals and clinics category is expected to develop at the fastest CAGR throughout the projection period. The segment's profitable expansion may be linked to an increase in the number of pipeline developments over the last few years. According to CRI, the number of cell therapy treatment projects climbed from 753 in 2018 to 1,011 in 2019.

Due to population growth, a growing geriatric population, and increased awareness among healthcare entities and patients about the potential of these therapies in chronic disease management, Asia-Pacific presents lucrative opportunities for key players operating in the cell therapy market. Furthermore, rising healthcare expenditures and the development of guidelines are projected to drive market expansion in the area.

Kolon Tissue Gene, Inc., Osiris Therapeutics, Inc., JCR Pharmaceuticals Co. Ltd., NuVasive, Inc., Stemedica Cell Technologies, Inc., Cells for Cells, Holostem Terapie Avanzate S.r.l., Mesoblast Ltd., and Medipost Co., Ltd. are among the leading companies operating in the global cell therapy market.

Study Coverage

  • This report illustrates the most vital attributes of the Cell Therapy Technologies Market, which are driving and providing opportunities.
  • This research gives an in-depth analysis of the Cell Therapy Technologies Market growth on the basis of several segments in the market.
  • This report presents the predictions of the past and present trends of the Cell Therapy Technologies Market.
  • This study also presents the competitive analysis, such as key strategies and capabilities of major players of the Cell Therapy Technologies Market.

Table of Contents

1. Executive Summary
2. Industry Outlook
2.1. Industry Overview
2.2. Industry Trends
3. Market Snapshot
3.1. Market Definition
3.2. Market Outlook
3.2.1. Porter Five Forces
3.3. Related Markets
4. Market characteristics
4.1. Market Overview
4.2. Market Segmentation
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. DRO - Impact Analysis
5. Therapy Type: Market Size & Analysis
5.1. Overview
5.2. Allogeneic Therapies
5.3. Autologous Therapies
6. Therapeutic Area: Market Size & Analysis
6.1. Overview
6.2. Oncology
6.3. Cardiovascular Disease (CVD)
6.4. Musculoskeletal Disorders
6.5. Dermatology
6.6. Others
7. Geography: Market Size & Analysis
7.1. Overview
7.2. North America (U.S., Mexico, Canada)
7.3. Europe (France, Germany, UK, Italy, Netherlands, Spain, Russia, Rest of Europe)
7.4. Asia Pacific (Japan, China, India, Australia, South East Asia, Rest of APAC)
7.5. Latin America (Brazil, Argentina)
7.6. Middle East & Africa (Saudi Arabia, UAE, South Africa, Rest of Middle East and Africa)
8. Competitive Landscape
8.1. Competitor Comparison Analysis
8.2. Market Developments
8.2.1. Mergers and Acquisitions, Legal, Awards, Partnerships
8.2.2. Product Launches and execution
9. Vendor Profiles
9.1. Novartis AG
9.1.1. Overview
9.1.2. Financial Overview
9.1.3. Product Offerings
9.1.4. Developments
9.1.5. Business Strategy
9.2. Gilead Sciences, Inc.
9.2.1. Overview
9.2.2. Financial Overview
9.2.3. Product Offerings
9.2.4. Developments
9.2.5. Business Strategy
9.3. Bristol-Myers Squibb Company
9.3.1. Overview
9.3.2. Financial Overview
9.3.3. Product Offerings
9.3.4. Developments
9.3.5. Business Strategy
9.4. Johnson & Johnson Services, Inc
9.4.1. Overview
9.4.2. Financial Overview
9.4.3. Product Offerings
9.4.4. Developments
9.4.5. Business Strategy
9.5. JCR Pharmaceuticals Co., Ltd.
9.5.1. Overview
9.5.2. Financial Overview
9.5.3. Product Offerings
9.5.4. Developments
9.5.5. Business Strategy
9.6. Tego Science
9.6.1. Overview
9.6.2. Financial Overview
9.6.3. Product Offerings
9.6.4. Developments
9.6.5. Business Strategy
9.7. Atara Biotherapeutics
9.7.1. Overview
9.7.2. Financial Overview
9.7.3. Product Offerings
9.7.4. Developments
9.7.5. Business Strategy
9.8. Takeda Pharmaceutical Company Limited
9.8.1. Overview
9.8.2. Financial Overview
9.8.3. Product Offerings
9.8.4. Developments
9.8.5. Business Strategy
9.9. Bluebird Bio, Inc.
9.9.1. Overview
9.9.2. Financial Overview
9.9.3. Product Offerings
9.9.4. Developments
9.9.5. Business Strategy
9.10. Dendreon Corp.
9.10.1. Overview
9.10.2. Financial Overview
9.10.3. Product Offerings
9.10.4. Developments
9.10.5. Business Strategy
10. Analyst Opinion
11. Annexure
11.1. Report Scope
11.2. Market Definitions
11.3. Research Methodology
11.3.1. Data Collation and In-house Estimation
11.3.2. Market Triangulation
11.3.3. Forecasting
11.4. Report Assumptions
11.5. Declarations
11.6. Stakeholders
11.7. Abbreviations
List of Tables
Table 1. Cell Therapy Technologies Market Value, by Therapy Type, 2021-2030 (USD Billion)
Table 2. Cell Therapy Technologies Market Value for Allogeneic Therapies, by Geography, 2021-2030 (USD Billion)
Table 3. Cell Therapy Technologies Market Value for Autologous Therapies, by Geography, 2021-2030 (USD Billion)
Table 4. Cell Therapy Technologies Market Value, by Therapeutic Area, 2021-2030 (USD Billion)
Table 5. Cell Therapy Technologies Market Value for Oncology, by Geography, 2021-2030 (USD Billion)
Table 6. Cell Therapy Technologies Market Value for Cardiovascular Disease (Cvd), by Geography, 2021-2030 (USD Billion)
Table 7. Cell Therapy Technologies Market Value for Musculoskeletal Disorders, by Geography, 2021-2030 (USD Billion)
Table 8. Cell Therapy Technologies Market Value for Dermatology,2021-2030 (USD Billion)
Table 9. Cell Therapy Technologies Market Value for Others, by Geography, 2021-2030 (USD Billion)
Table 10. North America Cell Therapy Technologies Market Value, by Country, 2021-2030 (USD Billion)
Table 11. North America Cell Therapy Technologies Market Value, by Therapy Type, 2021-2030 (USD Billion)
Table 12. North America Cell Therapy Technologies Market Value, by Therapeutic Area, 2021-2030 (USD Billion)
Table 13. North America Cell Therapy Technologies Market Value, by Region, 2021-2030 (USD Billion)
Table 14. U.S Cell Therapy Technologies Market Value, by Therapy Type, 2021-2030 (USD Billion)
Table 15. U.S Cell Therapy Technologies Market Value, by Therapeutic Area, 2021-2030 (USD Billion)
Table 16. U.S Cell Therapy Technologies Market Value, by Region, 2021-2030 (USD Billion)
Table 17. Canada Cell Therapy Technologies Market Value, by Therapy Type, 2021-2030 (USD Billion)
Table 18. Canada Cell Therapy Technologies Market Value, by Therapeutic Area, 2021-2030 (USD Billion)
Table 19. Canada Cell Therapy Technologies Market Value, by Region, 2021-2030 (USD Billion)
Table 20. Mexico Cell Therapy Technologies Market Value, by Therapy Type, 2021-2030 (USD Billion)
Table 21. Mexico Cell Therapy Technologies Market Value, by Therapeutic Area, 2021-2030 (USD Billion)
Table 22. Mexico Cell Therapy Technologies Market Value, by Region, 2021-2030 (USD Billion)
Table 23. Europe Cell Therapy Technologies Market Value, by Country, 2021-2030 (USD Billion)
Table 24. Europe Cell Therapy Technologies Market Value, by Therapy Type, 2021-2030 (USD Billion)
Table 25. Europe Cell Therapy Technologies Market Value, by Therapeutic Area, 2021-2030 (USD Billion)
Table 26. Europe Cell Therapy Technologies Market Value, by Region, 2021-2030 (USD Billion)
Table 27. Germany Cell Therapy Technologies Market Value, by Therapy Type, 2021-2030 (USD Billion)
Table 28. Germany Cell Therapy Technologies Market Value, by Therapeutic Area, 2021-2030 (USD Billion)
Table 29. Germany Cell Therapy Technologies Market Value, by Region, 2021-2030 (USD Billion)
Table 30. U.K Cell Therapy Technologies Market Value, by Therapy Type, 2021-2030 (USD Billion)
Table 31. U.K Cell Therapy Technologies Market Value, by Therapeutic Area, 2021-2030 (USD Billion)
Table 32. U.K Cell Therapy Technologies Market Value, by Region, 2021-2030 (USD Billion)
Table 33. France Cell Therapy Technologies Market Value, by Therapy Type, 2021-2030 (USD Billion)
Table 34. France Cell Therapy Technologies Market Value, by Therapeutic Area, 2021-2030 (USD Billion)
Table 35. France Cell Therapy Technologies Market Value, by Region, 2021-2030 (USD Billion)
Table 36. Italy Cell Therapy Technologies Market Value, by Therapy Type, 2021-2030 (USD Billion)
Table 37. Italy Cell Therapy Technologies Market Value, by Therapeutic Area, 2021-2030 (USD Billion)
Table 38. Italy Cell Therapy Technologies Market Value, by Region, 2021-2030 (USD Billion)
Table 39. Spain Cell Therapy Technologies Market Value, by Therapy Type, 2021-2030 (USD Billion)
Table 40. Spain Cell Therapy Technologies Market Value, by Therapeutic Area, 2021-2030 (USD Billion)
Table 41. Spain Cell Therapy Technologies Market Value, by Region, 2021-2030 (USD Billion)
Table 42. RoE Cell Therapy Technologies Market Value, by Therapy Type, 2021-2030 (USD Billion)
Table 43. RoE Cell Therapy Technologies Market Value, by Therapeutic Area, 2021-2030 (USD Billion)
Table 44. RoE Cell Therapy Technologies Market Value, by Region, 2021-2030 (USD Billion)
Table 45. Asia-Pacific Cell Therapy Technologies Market Value, by Country, 2021-2030 (USD Billion)
Table 46. Asia-Pacific Cell Therapy Technologies Market Value, by Therapy Type, 2021-2030 (USD Billion)
Table 47. Asia-Pacific Cell Therapy Technologies Market Value, by Therapeutic Area, 2021-2030 (USD Billion)
Table 48. Asia-Pacific Cell Therapy Technologies Market Value, by Region, 2021-2030 (USD Billion)
Table 49. China Cell Therapy Technologies Market Value, by Therapy Type, 2021-2030 (USD Billion)
Table 50. China Cell Therapy Technologies Market Value, by Therapeutic Area, 2021-2030 (USD Billion)
Table 51. China Cell Therapy Technologies Market Value, by Region, 2021-2030 (USD Billion)
Table 52. India Cell Therapy Technologies Market Value, by Therapy Type, 2021-2030 (USD Billion)
Table 53. India Cell Therapy Technologies Market Value, by Therapeutic Area, 2021-2030 (USD Billion)
Table 54. India Cell Therapy Technologies Market Value, by Region, 2021-2030 (USD Billion)
Table 55. Japan Cell Therapy Technologies Market Value, by Therapy Type, 2021-2030 (USD Billion)
Table 56. Japan Cell Therapy Technologies Market Value, by Therapeutic Area, 2021-2030 (USD Billion)
Table 57. Japan Cell Therapy Technologies Market Value, by Region, 2021-2030 (USD Billion)
Table 58. Rest of APAC Cell Therapy Technologies Market Value, by Therapy Type, 2021-2030 (USD Billion)
Table 59. Rest of APAC Cell Therapy Technologies Market Value, by Therapeutic Area, 2021-2030 (USD Billion)
Table 60. Rest of APAC Cell Therapy Technologies Market Value, by Region, 2021-2030 (USD Billion)
Table 61. Latin America Cell Therapy Technologies Market Value, by Therapy Type, 2021-2030 (USD Billion)
Table 62. Latin America Cell Therapy Technologies Market Value, by Therapeutic Area, 2021-2030 (USD Billion)
Table 63. Latin America Cell Therapy Technologies Market Value, by Region, 2021-2030 (USD Billion)
Table 64. Brazil Cell Therapy Technologies Market Value, by Therapy Type, 2021-2030 (USD Billion)
Table 65. Brazil Cell Therapy Technologies Market Value, by Therapeutic Area, 2021-2030 (USD Billion)
Table 66. Brazil Cell Therapy Technologies Market Value, by Region, 2021-2030 (USD Billion)
Table 67. Argentina Cell Therapy Technologies Market Value, by Therapy Type, 2021-2030 (USD Billion)
Table 68. Argentina Cell Therapy Technologies Market Value, by Therapeutic Area, 2021-2030 (USD Billion)
Table 69. Argentina Cell Therapy Technologies Market Value, by Region, 2021-2030 (USD Billion)
Table 70. Middle East and Africa Cell Therapy Technologies Market Value, by Therapy Type, 2021-2030 (USD Billion)
Table 71. Middle East and Africa Cell Therapy Technologies Market Value, by Therapeutic Area, 2021-2030 (USD Billion)
Table 72. Middle East and Africa Cell Therapy Technologies Market Value, by Region, 2021-2030 (USD Billion)
Table 73. Saudi Arabia Cell Therapy Technologies Market Value, by Therapy Type, 2021-2030 (USD Billion)
Table 74. Saudi Arabia Cell Therapy Technologies Market Value, by Therapeutic Area, 2021-2030 (USD Billion)
Table 75. Saudi Arabia Cell Therapy Technologies Market Value, by Region, 2021-2030 (USD Billion)
Table 76. UAE Cell Therapy Technologies Market Value, by Therapy Type, 2021-2030 (USD Billion)
Table 77. UAE Cell Therapy Technologies Market Value, by Therapeutic Area, 2021-2030 (USD Billion)
Table 78. UAE Cell Therapy Technologies Market Value, by Region, 2021-2030 (USD Billion)
Table 79. Rest of Middle East and Africa Cell Therapy Technologies Market Value, by Therapy Type, 2021-2030 (USD Billion)
Table 80. Rest of Middle East and Africa Cell Therapy Technologies Market Value, by Therapeutic Area, 2021-2030 (USD Billion)
Table 81. Rest of Middle East and Africa Cell Therapy Technologies Market Value, by Region, 2021-2030 (USD Billion)
Table 82. Novartis Ag: Financials
Table 83. Novartis Ag: Products & Services
Table 84. Novartis Ag: Recent Developments
Table 85. Gilead Sciences, Inc.: Financials
Table 86. Gilead Sciences, Inc.: Products & Services
Table 87. Gilead Sciences, Inc.: Recent Developments
Table 88. Bristol-Myers Squibb Company: Financials
Table 89. Bristol-Myers Squibb Company: Products & Services
Table 90. Bristol-Myers Squibb Company: Recent Developments
Table 91. Johnson & Johnson Services, Inc: Financials
Table 92. Johnson & Johnson Services, Inc: Products & Services
Table 93. Johnson & Johnson Services, Inc: Recent Developments
Table 94. Jcr Pharmaceuticals Co. Ltd.: Financials
Table 95. Jcr Pharmaceuticals Co. Ltd.: Products & Services
Table 96. Jcr Pharmaceuticals Co. Ltd.: Recent Developments
Table 97. Tego Science: Financials
Table 98. Tego Science: Products & Services
Table 99. Tego Science: Recent Developments
Table 100. Atara Biotherapeutics: Financials
Table 101. Atara Biotherapeutics: Products & Services
Table 102. Atara Biotherapeutics: Developments
Table 103. Takeda Pharmaceutical Company Limited: Financials
Table 104. Takeda Pharmaceutical Company Limited: Products & Services
Table 105. Takeda Pharmaceutical Company Limited: Recent Developments
Table 106. Bluebird Bio, Inc.: Financials
Table 107. Bluebird Bio, Inc.: Products & Services
Table 108. Bluebird Bio, Inc.: Recent Developments
Table 109. Dendreon Corp.: Financials
Table 110. Dendreon Corp.: Products & Services
Table 111. Dendreon Corp.: Recent Developments
List of Charts
Chart 1. Cell Therapy Technologies Market Value, by Therapy Type, 2021-2030 (USD Billion)
Chart 2. Cell Therapy Technologies Market Value for Allogeneic Therapies, by Geography, 2021-2030 (USD Billion)
Chart 3. Cell Therapy Technologies Market Value for Autologous Therapies, by Geography, 2021-2030 (USD Billion)
Chart 4. Cell Therapy Technologies Market Value, by Therapeutic Area, 2021-2030 (USD Billion)
Chart 5. Cell Therapy Technologies Market Value for Oncology, by Geography, 2021-2030 (USD Billion)
Chart 6. Cell Therapy Technologies Market Value for Cardiovascular Disease (Cvd), by Geography, 2021-2030 (USD Billion)
Chart 7. Cell Therapy Technologies Market Value for Musculoskeletal Disorders, by Geography, 2021-2030 (USD Billion)
Chart 8. Cell Therapy Technologies Market Value for Dermatology,2021-2030 (USD Billion)
Chart 9. Cell Therapy Technologies Market Value for Others, by Geography, 2021-2030 (USD Billion)
Chart 10. North America Cell Therapy Technologies Market Value, by Country, 2021-2030 (USD Billion)
Chart 11. North America Cell Therapy Technologies Market Value, by Therapy Type, 2021-2030 (USD Billion)
Chart 12. North America Cell Therapy Technologies Market Value, by Therapeutic Area, 2021-2030 (USD Billion)
Chart 13. North America Cell Therapy Technologies Market Value, by Region, 2021-2030 (USD Billion)
Chart 14. U.S Cell Therapy Technologies Market Value, by Therapy Type, 2021-2030 (USD Billion)
Chart 15. U.S Cell Therapy Technologies Market Value, by Therapeutic Area, 2021-2030 (USD Billion)
Chart 16. U.S Cell Therapy Technologies Market Value, by Region, 2021-2030 (USD Billion)
Chart 17. Canada Cell Therapy Technologies Market Value, by Therapy Type, 2021-2030 (USD Billion)
Chart 18. Canada Cell Therapy Technologies Market Value, by Therapeutic Area, 2021-2030 (USD Billion)
Chart 19. Canada Cell Therapy Technologies Market Value, by Region, 2021-2030 (USD Billion)
Chart 20. Mexico Cell Therapy Technologies Market Value, by Therapy Type, 2021-2030 (USD Billion)
Chart 21. Mexico Cell Therapy Technologies Market Value, by Therapeutic Area, 2021-2030 (USD Billion)
Chart 22. Mexico Cell Therapy Technologies Market Value, by Region, 2021-2030 (USD Billion)
Chart 23. Europe Cell Therapy Technologies Market Value, by Country, 2021-2030 (USD Billion)
Chart 24. Europe Cell Therapy Technologies Market Value, by Therapy Type, 2021-2030 (USD Billion)
Chart 25. Europe Cell Therapy Technologies Market Value, by Therapeutic Area, 2021-2030 (USD Billion)
Chart 26. Europe Cell Therapy Technologies Market Value, by Region, 2021-2030 (USD Billion)
Chart 27. Germany Cell Therapy Technologies Market Value, by Therapy Type, 2021-2030 (USD Billion)
Chart 28. Germany Cell Therapy Technologies Market Value, by Therapeutic Area, 2021-2030 (USD Billion)
Chart 29. Germany Cell Therapy Technologies Market Value, by Region, 2021-2030 (USD Billion)
Chart 30. U.K Cell Therapy Technologies Market Value, by Therapy Type, 2021-2030 (USD Billion)
Chart 31. U.K Cell Therapy Technologies Market Value, by Therapeutic Area, 2021-2030 (USD Billion)
Chart 32. U.K Cell Therapy Technologies Market Value, by Region, 2021-2030 (USD Billion)
Chart 33. France Cell Therapy Technologies Market Value, by Therapy Type, 2021-2030 (USD Billion)
Chart 34. France Cell Therapy Technologies Market Value, by Therapeutic Area, 2021-2030 (USD Billion)
Chart 35. France Cell Therapy Technologies Market Value, by Region, 2021-2030 (USD Billion)
Chart 36. Italy Cell Therapy Technologies Market Value, by Therapy Type, 2021-2030 (USD Billion)
Chart 37. Italy Cell Therapy Technologies Market Value, by Therapeutic Area, 2021-2030 (USD Billion)
Chart 38. Italy Cell Therapy Technologies Market Value, by Region, 2021-2030 (USD Billion)
Chart 39. Spain Cell Therapy Technologies Market Value, by Therapy Type, 2021-2030 (USD Billion)
Chart 40. Spain Cell Therapy Technologies Market Value, by Therapeutic Area, 2021-2030 (USD Billion)
Chart 41. Spain Cell Therapy Technologies Market Value, by Region, 2021-2030 (USD Billion)
Chart 42. RoE Cell Therapy Technologies Market Value, by Therapy Type, 2021-2030 (USD Billion)
Chart 43. RoE Cell Therapy Technologies Market Value, by Therapeutic Area, 2021-2030 (USD Billion)
Chart 44. RoE Cell Therapy Technologies Market Value, by Region, 2021-2030 (USD Billion)
Chart 45. Asia-Pacific Cell Therapy Technologies Market Value, by Country, 2021-2030 (USD Billion)
Chart 46. Asia-Pacific Cell Therapy Technologies Market Value, by Therapy Type, 2021-2030 (USD Billion)
Chart 47. Asia-Pacific Cell Therapy Technologies Market Value, by Therapeutic Area, 2021-2030 (USD Billion)
Chart 48. Asia-Pacific Cell Therapy Technologies Market Value, by Region, 2021-2030 (USD Billion)
Chart 49. China Cell Therapy Technologies Market Value, by Therapy Type, 2021-2030 (USD Billion)
Chart 50. China Cell Therapy Technologies Market Value, by Therapeutic Area, 2021-2030 (USD Billion)
Chart 51. China Cell Therapy Technologies Market Value, by Region, 2021-2030 (USD Billion)
Chart 52. India Cell Therapy Technologies Market Value, by Therapy Type, 2021-2030 (USD Billion)
Chart 53. India Cell Therapy Technologies Market Value, by Therapeutic Area, 2021-2030 (USD Billion)
Chart 54. India Cell Therapy Technologies Market Value, by Region, 2021-2030 (USD Billion)
Chart 55. Japan Cell Therapy Technologies Market Value, by Therapy Type, 2021-2030 (USD Billion)
Chart 56. Japan Cell Therapy Technologies Market Value, by Therapeutic Area, 2021-2030 (USD Billion)
Chart 57. Japan Cell Therapy Technologies Market Value, by Region, 2021-2030 (USD Billion)
Chart 58. Rest of APAC Cell Therapy Technologies Market Value, by Therapy Type, 2021-2030 (USD Billion)
Chart 59. Rest of APAC Cell Therapy Technologies Market Value, by Therapeutic Area, 2021-2030 (USD Billion)
Chart 60. Rest of APAC Cell Therapy Technologies Market Value, by Region, 2021-2030 (USD Billion)
Chart 61. Latin America Cell Therapy Technologies Market Value, by Therapy Type, 2021-2030 (USD Billion)
Chart 62. Latin America Cell Therapy Technologies Market Value, by Therapeutic Area, 2021-2030 (USD Billion)
Chart 63. Latin America Cell Therapy Technologies Market Value, by Region, 2021-2030 (USD Billion)
Chart 64. Brazil Cell Therapy Technologies Market Value, by Therapy Type, 2021-2030 (USD Billion)
Chart 65. Brazil Cell Therapy Technologies Market Value, by Therapeutic Area, 2021-2030 (USD Billion)
Chart 66. Brazil Cell Therapy Technologies Market Value, by Region, 2021-2030 (USD Billion)
Chart 67. Argentina Cell Therapy Technologies Market Value, by Therapy Type, 2021-2030 (USD Billion)
Chart 68. Argentina Cell Therapy Technologies Market Value, by Therapeutic Area, 2021-2030 (USD Billion)
Chart 69. Argentina Cell Therapy Technologies Market Value, by Region, 2021-2030 (USD Billion)
Chart 70. Middle East and Africa Cell Therapy Technologies Market Value, by Therapy Type, 2021-2030 (USD Billion)
Chart 71. Middle East and Africa Cell Therapy Technologies Market Value, by Therapeutic Area, 2021-2030 (USD Billion)
Chart 72. Middle East and Africa Cell Therapy Technologies Market Value, by Region, 2021-2030 (USD Billion)
Chart 73. Saudi Arabia Cell Therapy Technologies Market Value, by Therapy Type, 2021-2030 (USD Billion)
Chart 74. Saudi Arabia Cell Therapy Technologies Market Value, by Therapeutic Area, 2021-2030 (USD Billion)
Chart 75. Saudi Arabia Cell Therapy Technologies Market Value, by Region, 2021-2030 (USD Billion)
Chart 76. UAE Cell Therapy Technologies Market Value, by Therapy Type, 2021-2030 (USD Billion)
Chart 77. UAE Cell Therapy Technologies Market Value, by Therapeutic Area, 2021-2030 (USD Billion)
Chart 78. UAE Cell Therapy Technologies Market Value, by Region, 2021-2030 (USD Billion)
Chart 79. Rest of Middle East and Africa Cell Therapy Technologies Market Value, by Therapy Type, 2021-2030 (USD Billion)
Chart 80. Rest of Middle East and Africa Cell Therapy Technologies Market Value, by Therapeutic Area, 2021-2030 (USD Billion)
Chart 81. Rest of Middle East and Africa Cell Therapy Technologies Market Value, by Region, 2021-2030 (USD Billion)
Chart 82. Novartis Ag: Financials
Chart 83. Novartis Ag: Products & Services
Chart 84. Novartis Ag: Recent Developments
Chart 85. Gilead Sciences, Inc.: Financials
Chart 86. Gilead Sciences, Inc.: Products & Services
Chart 87. Gilead Sciences, Inc.: Recent Developments
Chart 88. Bristol-Myers Squibb Company: Financials
Chart 89. Bristol-Myers Squibb Company: Products & Services
Chart 90. Bristol-Myers Squibb Company: Recent Developments
Chart 91. Johnson & Johnson Services, Inc: Financials
Chart 92. Johnson & Johnson Services, Inc: Products & Services
Chart 93. Johnson & Johnson Services, Inc: Recent Developments
Chart 94. Jcr Pharmaceuticals Co. Ltd.: Financials
Chart 95. Jcr Pharmaceuticals Co. Ltd.: Products & Services
Chart 96. Jcr Pharmaceuticals Co. Ltd.: Recent Developments
Chart 97. Tego Science: Financials
Chart 98. Tego Science: Products & Services
Chart 99. Tego Science: Recent Developments
Chart 100. Atara Biotherapeutics: Financials
Chart 101. Atara Biotherapeutics: Products & Services
Chart 102. Atara Biotherapeutics: Developments
Chart 103. Takeda Pharmaceutical Company Limited: Financials
Chart 104. Takeda Pharmaceutical Company Limited: Products & Services
Chart 105. Takeda Pharmaceutical Company Limited: Recent Developments
Chart 106. Bluebird Bio, Inc.: Financials
Chart 107. Bluebird Bio, Inc.: Products & Services
Chart 108. Bluebird Bio, Inc.: Recent Developments
Chart 109. Dendreon Corp.: Financials
Chart 110. Dendreon Corp.: Products & Services
Chart 111. Dendreon Corp.: Recent Developments

Companies Mentioned

  • Kolon Tissue Gene Inc.
  • Osiris Therapeutics Inc.
  • JCR Pharmaceuticals Co. Ltd.
  • NuVasive Inc.
  • Stemedica Cell Technologies Inc.
  • Cells for Cells
  • Holostem Terapie Avanzate S.r.l.
  • Mesoblast Ltd.
  • Medipost Co. Ltd.

Related Topics

Related Reports

Cell Therapy Market Size, Share & Trends Analysis Report by Therapy Type (Autologous (Stem Cell Therapies, Non-stem Cell Therapies), Allogeneic), Therapeutic Area, Region, and Segment Forecasts, 2024-2030 - Product Image

Cell Therapy Market Size, Share & Trends Analysis Report by Therapy Type (Autologous (Stem Cell Therapies, Non-stem Cell Therapies), Allogeneic), Therapeutic Area, Region, and Segment Forecasts, 2024-2030

  • Report
  • 110 Pages
  • Global
From
Allogeneic Cell Therapy Market by Type, Application, End-Use - Global Forecast 2025-2030 - Product Image

Allogeneic Cell Therapy Market by Type, Application, End-Use - Global Forecast 2025-2030

  • Report
  • 184 Pages
  • Global
From
Cell Therapy - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Image

Cell Therapy - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • 150 Pages
  • Global
From
Cell Therapy Technologies Market by Product, Process, Cell Type, End-User - Global Forecast 2025-2030 - Product Image

Cell Therapy Technologies Market by Product, Process, Cell Type, End-User - Global Forecast 2025-2030

  • Report
  • 183 Pages
  • Global
From
Cell Therapy Global Market Report 2024 - Product Image

Cell Therapy Global Market Report 2024

  • Report
  • 250 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.